| Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein BI Sikic, GA Fisher, BL Lum, J Halsey, L Beketic-Oreskovic, G Chen Cancer chemotherapy and pharmacology 40, S13-S19, 1997 | 356 | 1997 |
| Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol) C Dumontet, GE Duran, KA Steger, L Beketic-Oreskovic, BI Sikic Cancer research 56 (5), 1091-1097, 1996 | 150 | 1996 |
| Tumor markers in breast cancer–evaluation of their clinical usefulness P Marić, P Ozretić, S Levanat, S Orešković, K Antunac, ... Collegium antropologicum 35 (1), 241-247, 2011 | 138 | 2011 |
| Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdrl gene activation by the cyclosporin PSC 833 L Beketic-Oreskovic, GE Durán, G Chen, C Dumontet, BI Sikic JNCI: Journal of the National Cancer Institute 87 (21), 1593-1602, 1995 | 108 | 1995 |
| A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma S Oreskovic, D Babic, D Kalafatic, D Barisic, L Beketic-Oreskovic Gynecologic oncology 93 (1), 34-40, 2004 | 99 | 2004 |
| Conjunctival melanoma-epidemiological trends and features S Kaštelan, A Gverović Antunica, L Beketić Orešković, J Salopek Rabatić, ... Pathology & Oncology Research 24, 787-796, 2018 | 72 | 2018 |
| Fertility after breast cancer treatment M Kasum, L Beketić-Orešković, PF Peddi, S Orešković, RH Johnson European Journal of Obstetrics & Gynecology and Reproductive Biology 173, 13-18, 2014 | 67 | 2014 |
| MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells GK Chen, GE Durán, A Mangili, L Beketic-Oreskovic, BI Sikic British journal of cancer 83 (7), 892-898, 2000 | 55 | 2000 |
| Thrombosis following ovarian hyperstimulation syndrome M Kasum, D Danolić, S Orešković, D Ježek, L Beketić-Orešković, M Pekez Gynecological endocrinology 30 (11), 764-768, 2014 | 46 | 2014 |
| Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients P Ozretic, I Alvir, B Sarcevic, Z Vujaskovic, Z Rendic-Miocevic, A Roguljic, ... The International journal of biological markers 33 (1), 109-115, 2018 | 40 | 2018 |
| Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants P Vuković, FA Peccatori, C Massarotti, MS Miralles, L Beketić-Orešković, ... Critical Reviews in Oncology/Hematology 157, 103201, 2021 | 39 | 2021 |
| Fertility preservation in young women with early-stage breast cancer P Vuković, M Kasum, J Raguž, N Lonjak, S Bilić Knežević, I Orešković, ... Acta Clinica Croatica 58 (1.), 147-156, 2019 | 39 | 2019 |
| Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in breast cancer patients L Beketic-Oreskovic, P Ozretic, ZN Rabbani, IL Jackson, B Sarcevic, ... Pathology & Oncology Research 17, 593-603, 2011 | 36 | 2011 |
| Immunotherapy for uveal melanoma-current knowledge and perspectives S Kaštelan, AG Antunica, LB Oresković, G Pelčić, E Kasun, K Hat Current medicinal chemistry 27 (8), 1350-1366, 2020 | 28 | 2020 |
| Resistance of human larynx carcinoma cells to cisplatin, γ-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes M Osmak, L Beketić-Orešković, M Matulić, J Sorić Mutation Research Letters 303 (3), 113-120, 1993 | 26 | 1993 |
| Kirurška onkologija M Stanec, DV Vrdoljak, M Turić, L Beketić-Orešković, V Beroš, G Brozović Zagreb: Medicinska naklada, 294-302, 2011 | 25 | 2011 |
| Kliničke upute hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ... Liječnički vjesnik 137 (5-6), 0-0, 2015 | 24* | 2015 |
| Dopamine agonists in prevention of ovarian hyperstimulation syndrome M Kasum, H Vrčić, P Stanić, D Ježek, S Orešković, L Beketić-Orešković, ... Gynecological endocrinology 30 (12), 845-849, 2014 | 22 | 2014 |
| Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells L Beketic-Oreskovic, M Osmak Cancer chemotherapy and pharmacology 35, 327-333, 1995 | 21 | 1995 |
| Fertility preservation with ovarian stimulation protocols prior to cancer treatment M Kasum, V Šimunić, S Orešković, L Beketić-Orešković Gynecological endocrinology 30 (3), 182-186, 2014 | 20 | 2014 |
